Association between prealbumin, all-cause mortality, and response to nutrition treatment in patients at nutrition risk: Secondary analysis of a randomized controlled trial.
biomarker
malnutrition
nutrition support
outcomes
prealbumin
visceral proteins
Journal
JPEN. Journal of parenteral and enteral nutrition
ISSN: 1941-2444
Titre abrégé: JPEN J Parenter Enteral Nutr
Pays: United States
ID NLM: 7804134
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
27
12
2022
received:
29
09
2022
accepted:
29
12
2022
pubmed:
2
1
2023
medline:
4
3
2023
entrez:
1
1
2023
Statut:
ppublish
Résumé
Because of the shorter half-life as compared with albumin, serum prealbumin concentrations have been proposed to be useful nutrition biomarkers for the assessment of patients at nutrition risk. In a post hoc analysis of patients at nutrition risk from a randomized controlled nutrition trial, we tested the hypothesis that (1) prealbumin is associated with higher all-cause 180-day mortality rates and that (2) individualized nutrition support compared with usual-care nutrition more effectively improves survival at 30 days in patients with low prealbumin levels compared with patients with normal prealbumin levels. We performed a prespecified cohort study in patients included in the pragmatic, Swiss, multicenter randomized controlled EFFORT trial comparing the effects of individualized nutrition support with usual care. We studied low prealbumin concentrations (<0.17 g/L) in a subgroup of 517 patients from one participating center. A total of 306 (59.2%) patients (mean age 71.9 years, 53.6% men) had low admission prealbumin levels (<0.17 g/L). There was a significant association between low prealbumin levels and mortality at 180 days (115/306 [37.6%] vs 47/211 [22.3%], fully adjusted hazard ratio [HR]=1.59, 95% CI 1.11-2.28; P = 0.011). Prealbumin levels significantly improved the prognostic value of the Nutritional Risk Screening total score regarding mortality prediction at short- and long-term. The difference in mortality between patients receiving individualized nutrition support and usual-care nutrition was similar for patients with low prealbumin levels compared with patients with normal prealbumin levels (HR=0.90 [95% CI=0.51-1.59] vs HR=0.88 [95% CI=0.35-2.23]) with no evidence for interaction (P = 0.823). Among medical inpatients at nutrition risk, low admission prealbumin levels correlated with different nutrition markers and higher mortality risk, but patients with low or high prealbumin levels had a similar benefit from nutrition support. Further studies should identify nutrition markers that help further personalize nutrition interventions.
Sections du résumé
BACKGROUND
Because of the shorter half-life as compared with albumin, serum prealbumin concentrations have been proposed to be useful nutrition biomarkers for the assessment of patients at nutrition risk. In a post hoc analysis of patients at nutrition risk from a randomized controlled nutrition trial, we tested the hypothesis that (1) prealbumin is associated with higher all-cause 180-day mortality rates and that (2) individualized nutrition support compared with usual-care nutrition more effectively improves survival at 30 days in patients with low prealbumin levels compared with patients with normal prealbumin levels.
METHODS
We performed a prespecified cohort study in patients included in the pragmatic, Swiss, multicenter randomized controlled EFFORT trial comparing the effects of individualized nutrition support with usual care. We studied low prealbumin concentrations (<0.17 g/L) in a subgroup of 517 patients from one participating center.
RESULTS
A total of 306 (59.2%) patients (mean age 71.9 years, 53.6% men) had low admission prealbumin levels (<0.17 g/L). There was a significant association between low prealbumin levels and mortality at 180 days (115/306 [37.6%] vs 47/211 [22.3%], fully adjusted hazard ratio [HR]=1.59, 95% CI 1.11-2.28; P = 0.011). Prealbumin levels significantly improved the prognostic value of the Nutritional Risk Screening total score regarding mortality prediction at short- and long-term. The difference in mortality between patients receiving individualized nutrition support and usual-care nutrition was similar for patients with low prealbumin levels compared with patients with normal prealbumin levels (HR=0.90 [95% CI=0.51-1.59] vs HR=0.88 [95% CI=0.35-2.23]) with no evidence for interaction (P = 0.823).
CONCLUSION
Among medical inpatients at nutrition risk, low admission prealbumin levels correlated with different nutrition markers and higher mortality risk, but patients with low or high prealbumin levels had a similar benefit from nutrition support. Further studies should identify nutrition markers that help further personalize nutrition interventions.
Substances chimiques
Prealbumin
0
Biomarkers
0
Banques de données
ClinicalTrials.gov
['NCT02517476']
Types de publication
Randomized Controlled Trial
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
408-419Subventions
Organisme : Medical Research Council
ID : MR/P021220/1
Pays : United Kingdom
Informations de copyright
© 2023 American Society for Parenteral and Enteral Nutrition.
Références
Barker L, Gout B, Crowe T. Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system. Int J Environ Res Public Health. 2011;8(2):514-527.
Felder S, Lechtenboehmer C, Bally M, et al. Association of nutritional risk and adverse medical outcomes across different medical inpatient populations. Nutrition. 2015;31(11-12):1385-1393.
Schuetz P, Seres D, Lobo DN, Gomes F, Kaegi-Braun N, Stanga Z. Management of disease-related malnutrition for patients being treated in hospital. Lancet. 2021;398(10314):1927-1938.
McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ. 1994;308(6934):945-948.
Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393(10188):2312-2321.
Gomes F, Baumgartner A, Bounoure L, et al. Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: an updated systematic review and meta-analysis. JAMA Netw Open. 2019;2(11):e1915138.
Deutz NE, Matheson EM, Matarese LE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr. 2016;35(1):18-26.
Kaegi-Braun N, Faessli M, Kilchoer F, et al. Nutritional trials using high protein strategies and long duration of support show strongest clinical effects on mortality: results of an updated systematic review and meta-analysis. Clin Nutr Espen. 2021;45:45-54.
Kaegi-Braun N, Baumgartner A, Gomes F, Stanga Z, Deutz NE, Schuetz P. Evidence-based medical nutrition-a difficult journey, but worth the effort! Clin Nutr. 2020;39(10):3014-3018.
Merker M, Felder M, Gueissaz L, et al. Association of baseline inflammation with effectiveness of nutritional support among patients with disease-related malnutrition: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3(3):e200663.
Bargetzi A, Emmenegger N, Wildisen S, et al. Admission kidney function is a strong predictor for the response to nutritional support in patients at nutritional risk. Clin Nutr. 2021;40(5):2762-2771.
Kaegi-Braun N, Tribolet P, Baumgartner A, et al. Value of handgrip strength to predict clinical outcomes and therapeutic response in malnourished medical inpatients: secondary analysis of a randomized controlled trial. Am J Clin Nutr. 2021;114(2):731-740.
Bargetzi L, Bargetzi M, Laviano A, Stanga Z, Schuetz P. Inflammation reduces the effect of nutritional therapy on clinical outcomes in cancer patients. Ann Oncol. 2021;32(11):1451-1452.
Bretschera C, Boesiger F, Kaegi-Braun N, et al. Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: secondary analysis of a randomised clinical trial. EClin Med. 2022;45:101301.
Struja T, Laczko E, Wolski W, et al. Association of proteomic markers with nutritional risk and response to nutritional support: a secondary pilot study of the EFFORT trial using an untargeted proteomics approach. Clin Nutr Espen. 2022;48:282-290.
Struja T, Wolski W, Schapbach R, Mueller B, Laczko E, Schuetz P. Association of metabolomic markers and response to nutritional support: a secondary analysis of the EFFORT trial using an untargeted metabolomics approach. Clin Nutr. 2021;40(9):5062-5070.
Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr. 1977;1(1):11-21.
Bharadwaj S, Ginoya S, Tandon P, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf). 2016;4(4):272-280.
Beck FK, Rosenthal TC. Prealbumin: a marker for nutritional evaluation. Am Fam Physician. 2002;65(8):1575-1578.
Spiekerman AM. Nutritional assessment (protein nutriture). Anal Chem. 1995;67(12):429R-436RR.
Schuetz P, Fehr R, Baechli V, et al. Design and rationale of the effect of early nutritional therapy on frailty, functional outcomes and recovery of malnourished medical inpatients (EFFORT): a pragmatic, multicenter, randomized-controlled trial-protocol. Inter J Clin Trials. 2018;5(3):142-150.
Hersberger L, Bargetzi L, Bargetzi A, et al. Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trial. Clin Nutr. 2020;39(9):2720-2729.
Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc EWG. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321-336.
Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr. 2018;37(1):336-353.
Bounoure L, Gomes F, Stanga Z, et al. Detection and treatment of medical inpatients with or at-risk of malnutrition: suggested procedures based on validated guidelines. Nutrition. 2016;32(7-8):790-798.
MacDonald A, Hildebrandt L. Comparison of formulaic equations to determine energy expenditure in the critically ill patient. Nutrition. 2003;19(3):233-239.
Genton L, Pichard C. Protein catabolism and requirements in severe illness. Int J Vitam Nutr Res. 2011;81(2-3):143-152.
Potter JM, Roberts MA, McColl JH, Reilly JJ. Protein energy supplements in unwell elderly patients-a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2001;25(6):323-329.
Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev. 2009;2:CD003288.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
Evans DC, Corkins MR, Malone A, et al. The use of visceral proteins as nutrition markers: an ASPEN position paper. Nutr Clin Pract. 2021;36(1):22-28.
Delliere S, Pouga L, Neveux N, Hernvann A, De Bandt JP, Cynober L. Assessment of transthyretin cut-off values for a better screening of malnutrition: retrospective determination and prospective validation. Clin Nutr. 2021;40(3):907-911.
Kaegi-Braun N, Tribolet P, Gomes F, et al. Six-month outcomes after individualized nutritional support during the hospital stay in medical patients at nutritional risk: secondary analysis of a prospective randomized trial. Clin Nutr. 2021;40(3):812-819.
Keller U. Nutritional laboratory markers in malnutrition. J Clin Med. 2019;8(6):775.
Delliere S, Cynober L. Is transthyretin a good marker of nutritional status? Clin Nutr. 2017;36(2):364-370.
Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11):1045-1056.
Hutchinson DR, Halliwell RP, Smith MG, Parke DV. Serum “prealbumin” as an index of liver function in human hepatobiliary disease. Clin Chim Acta. 1981;114(1):69-74.
Ingenbleek Y. Plasma transthyretin as a biomarker of sarcopenia in elderly subjects. Nutrients. 2019;11(4):895.
Smith SH. Using albumin and prealbumin to assess nutritional status. Nursing. 2017;47(4):65-66.
Hagve M, Gjessing P, Ytrebo LM, Irtun O. Nutritional support for critically ill patients in the intensive care unit. Tidsskr Nor Laegeforen. 2020;140(2).
Singer P. Preserving the quality of life: nutrition in the ICU. Crit Care. 2019;23(Suppl 1):139.
Zhang Z, Pereira SL, Luo M, Matheson EM. Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients. 2017;9(8):829.
Drescher T, Singler K, Ulrich A, et al. Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients. Eur J Clin Nutr. 2010;64(8):887-893.